Iovance Biotherapeutics market cap IOVA

Share price times shares outstanding: what the whole company sells for, since 2011.

Iovance Biotherapeutics is worth $6.4B at the close on Oct 23, 2026, at $14.09 a share.

That is up 684% over the last year and up 72% over five years.

Its highest close in our data was $7.5B in Jan 2021.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$6.4B	$936.8M	$6.6B	+464%
2025	$1.1B	$554.3M	$2.3B	−50%
2024	$2.2B	$1.9B	$4.7B	+8%
2023	$2.1B	$825.1M	$2.1B	+106%
2022	$1B	$966M	$2.9B	−66%
2021	$3B	$2.6B	$7.5B	−56%
2020	$6.8B	$2.7B	$7.3B	+94%
2019	$3.5B	$1.1B	$3.7B	+217%
2018	$1.1B	$606.5M	$1.7B	+91%
2017	$581.1M	$294.6M	$657.3M	+35%
2016	$431.5M	$222.9M	$537.6M	+17%
2015	$369.3M	$201.8M	$599.1M	+60%
2014	$230.5M	$92.4M	$236M	+9%
2013	$211.6M	$782.9K	$211.6M	+1490%
2012	$13.3M	$12.5M	$99.4M	−82%
2011	$73.6M	$69.9M	$106.4M	n/a

Companies in Biotechnology nearest Iovance Biotherapeutics' size, closest first, today.

Company	Market cap
IOVAIovance Biotherapeutics	$6.4B
KRYSKrystal Biotech	$9.2B
RGENRepligen	$10B
TECHBIO-TECHNE	$11.4B
HALOHalozyme Therapeutics	$14.3B
NBIXNeurocrine Biosciences	$14.5B
EXELExelixis	$16B
ADMAAdma Biologics	$2.4B
VCELVericel	$2.2B
INCYIncyte	$23.5B
UTHRUnited Therapeutics	$25.2B
Peer median	$12.8B